Pathogenesis and management of myocardial injury in coronavirus disease 2019

The outbreak of coronavirus disease 2019 (COVID‐19), caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection, has become a major health crisis and a worldwide pandemic. COVID‐19 is characterized by high infectivity, long incubation period, diverse clinical presentations, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Zhi‐Yao, Geng, Yong‐Jian, Huang, Ji, Qian, Hai‐Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2020
Materias:
Focus on Sex, Comorbidities and Medical Treatment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7405025/
https://www.ncbi.nlm.nih.gov/pubmed/32683753
http://dx.doi.org/10.1002/ejhf.1967
Descripción
Sumario:The outbreak of coronavirus disease 2019 (COVID‐19), caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection, has become a major health crisis and a worldwide pandemic. COVID‐19 is characterized by high infectivity, long incubation period, diverse clinical presentations, and strong transmission intensity. COVID‐19 can cause myocardial injury as well as other cardiovascular complications, particularly in senior patients with pre‐existing medical conditions. The current review summarizes the epidemiological characteristics, potential mechanisms, clinical manifestations, and recent progress in the management of COVID‐19 cardiovascular complications.

Ejemplares similares